Press Releases

ST JULIANS, Malta, June 4, 2024 /PRNewswire/ -- Reference is made to today's announcement from Gaming Innovation Group Inc. (GiG) regarding a SEK 100 million directed share issue.

Jonas Warrer Petersen Holding ApS, a company owned by Jonas Warrer, Group CEO and primary insider of Gaming Innovation Group Inc. (GiG), has participated in the share issue with 18,338 shares at a price of SEK 31.00 per share. After this transaction, Jonas Warrer holds 60,000 options in GiG... (continue reading...)

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Toyota Motor Corporation (NYSE: TM) resulting from allegations that Toyota may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Toyota securities you may be entitled to compensation without payment of any out of pocket fees... (continue reading...)

DUBAI, UAE - (NewMediaWire) - June 04, 2024 - Blackwell 3D Construction Corp. (OTC: BDCC) ("Blackwell 3D or the "Company"), an innovative 3D house printing technology company focused on revolutionizing the construction industry by printing environmentally friendly 3D homes in a fraction of the time and at a fraction of the cost of traditional homes, is pleased to unveil the formation of its subsidiary in the Philippines, dedicated to advancing affordable housing... (continue reading...)

PARIS, France, June 4, 2024 – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, held its ordinary and extraordinary general meeting of shareholders on May 30, 2024 (the “General Meeting”), which was chaired by Mr. Marc de... (continue reading...)

BOSTON--(BUSINESS WIRE)-- Astria Therapeutics, Inc. (Nasdaq: ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase 40,000 shares of Astria’s common stock on June 3, 2024 under Astria’s 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an... (continue reading...)